A carregar...
Future perspectives in target-specific immunotherapies of myasthenia gravis
Myasthenia gravis (MG) is an autoimmune disease caused by complement-fixing antibodies against acetylcholine receptors (AChR); antigen-specific CD4+ T cells, regulatory T cells (Tregs) and T helper (Th) 17+ cells are essential in antibody production. Target-specific therapeutic interventions should...
Na minha lista:
| Publicado no: | Ther Adv Neurol Disord |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4643871/ https://ncbi.nlm.nih.gov/pubmed/26600875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285615605700 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|